Stockholders' Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 11, 2021 |
Apr. 13, 2021 |
Jan. 19, 2021 |
Nov. 03, 2020 |
Aug. 14, 2020 |
Jun. 03, 2020 |
Feb. 15, 2021 |
Jan. 25, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2018 |
Jun. 08, 2021 |
Mar. 28, 2021 |
Jan. 29, 2021 |
Nov. 12, 2020 |
Sep. 30, 2018 |
|
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Preferred stock, authorized (in Shares) | 5,000,000 | 5,000,000 | 10,000,000 | |||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||||
| Preferred shares designated (in Shares) | 5,000,000 | 5,000,000 | ||||||||||||||||||
| Certificate of designation series A preferred stock (in Shares) | 5,000,000 | |||||||||||||||||||
| Conversion trigger, percentage | 25.00% | |||||||||||||||||||
| Conversion trigger, per share (in Dollars per share) | $ 6.00 | |||||||||||||||||||
| Effective interest rate | 25.00% | 25.00% | ||||||||||||||||||
| Effective conversion price | $ 6.00 | $ 6.00 | ||||||||||||||||||
| Common stock, authorized (in Shares) | 116,666,667 | 116,666,667 | 116,666,667 | |||||||||||||||||
| Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||||
| Common stock, shares issued (in Shares) | 34,038,707 | 34,038,707 | 34,038,707 | |||||||||||||||||
| Aggregate of shares (in Shares) | 8,142,894 | |||||||||||||||||||
| Shares issued (in Shares) | 7,360,000 | 6,400,000 | 116,666,667 | |||||||||||||||||
| Purchase additional shares (in Shares) | 960,000 | |||||||||||||||||||
| Common stock public price (in Dollars per share) | $ 6.51 | |||||||||||||||||||
| Public price (in Dollars per share) | $ 7.00 | |||||||||||||||||||
| Underwriter expenses | $ 47,523,583 | |||||||||||||||||||
| Reverse stock split, description | On November 3, 2020, the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”). | |||||||||||||||||||
| Capital value | $ 150,000,000 | |||||||||||||||||||
| Purchase aggregate description | During the six months ended June 30, 2020, the Company’s Board issued (i) Warrants to purchase an aggregate of 279,460 shares of Common Stock with an exercise price of $7.50 per share and (ii) Warrants to purchase an aggregate of 9,793 shares of Common Stock with an exercise price of $6.39 per share. | |||||||||||||||||||
| Number of warrants to purchase of common stock (in Shares) | 6,667 | 131,271 | 6,667 | |||||||||||||||||
| Weighted-average contractual remaining life | 1 year 9 months 18 days | |||||||||||||||||||
| Exercise price (in Dollars per share) | $ 8.72 | $ 9.75 | $ 9.75 | |||||||||||||||||
| Warrants value | $ 65,003 | $ 1,279,892 | $ 65,003 | |||||||||||||||||
| Common stock reserved for issuance (in Shares) | 50,000 | |||||||||||||||||||
| Stock options to purchase of common stock (in Shares) | 643,006 | 593,006 | 643,006 | 568,006 | ||||||||||||||||
| Stock options exercise price (in Dollars per share) | $ 7.03 | $ 7.63 | $ 7.03 | $ 7.39 | ||||||||||||||||
| Fair value per share (in Dollars per share) | $ 2.64 | |||||||||||||||||||
| Stock compensation expense | $ 190,357 | $ 737,306 | ||||||||||||||||||
| Share based compensation | $ 287,519 | $ 752,785 | ||||||||||||||||||
| Stock-based compensation | 0 | $ 0 | ||||||||||||||||||
| Compensation, description | the Compensation Committee approved the following grants: (a) for Messrs. Cohen, Reisfield and Silverman (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (b) for Mr. Seidl and Ms. Sood (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (ii) 10,000 restricted stock units pursuant to the 2018 Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The 5,000 restricted stock units granted to each of Messrs. Cohen, Reisfield, Silverman and Seidl and Ms. Sood vest in four successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. The 10,000 restricted stock units granted to Mr. Seidl and Ms. Sood vest in eight successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. All restricted stock units granted to these directors shall vest in full immediately upon a change in control. The company recognized stock-based compensation of $111,300 and $222,600 for the three and six months ended June 30, 2021. As of June 30, 2021, the unrecognized compensation expense was $349,800. | |||||||||||||||||||
| Stock Options [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Stock options to purchase of common stock (in Shares) | 25,000 | 90,000 | ||||||||||||||||||
| Stock-based compensation expense | $ 514,866 | |||||||||||||||||||
| Options term | 10 years | 10 years | ||||||||||||||||||
| Stock options exercise price (in Dollars per share) | $ 12.92 | $ 12.72 | ||||||||||||||||||
| Weighted average grant-date fair value (in Dollars per share) | $ 5.82 | $ 5.72 | ||||||||||||||||||
| Unrecognized compensation expense | 224,000 | $ 224,000 | ||||||||||||||||||
| Weighted-average contractual remaining life | 1 year 3 months 18 days | |||||||||||||||||||
| Thomas Bushey [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Recognized stock based compensation | 0 | $ 1,050,000 | ||||||||||||||||||
| Restricted Stock Units (RSUs) [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Weighted-average contractual remaining life | 1 year 3 months | |||||||||||||||||||
| Weighted average grant-date fair value (in Dollars per share) | $ 0.64 | |||||||||||||||||||
| Unrecognized compensation expense | $ 5,250,000 | |||||||||||||||||||
| Stock compensation expense | $ 3,150,000 | |||||||||||||||||||
| Restricted stock purchase (in Shares) | 1,000,000 | 126,160 | ||||||||||||||||||
| Weighted average grant-date fair value of exercise price (in Dollars per share) | $ 8.40 | |||||||||||||||||||
| Vesting period | 2 years | 2 years | ||||||||||||||||||
| Restricted Stock Units (RSUs) [Member] | Thomas Bushey [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Description of restricted stock units | Effective January 19, 2021, (i) Mr. Bushey received 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares were canceled. | |||||||||||||||||||
| Consultant [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Stock compensation expense | $ 0 | $ 10,120 | ||||||||||||||||||
| Director [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Stock compensation expense | 270,000 | |||||||||||||||||||
| Recognized stock based compensation | $ 0 | $ 90,000 | ||||||||||||||||||
| Director [Member] | Restricted Stock Units (RSUs) [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | $ 60,000 | |||||||||||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Preferred stock, authorized (in Shares) | 5,000,000 | 5,000,000 | 5,000,000 | |||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||||
| Preferred shares designated (in Shares) | 5,000,000 | 5,000,000 | ||||||||||||||||||
| 2018 Equity Incentive Plan [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Common stock reserved for issuance (in Shares) | 3,333,334 | |||||||||||||||||||
| Preferred Stock [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Preferred stock, authorized (in Shares) | 10,000,000 | 10,000,000 | ||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Number of warrants to purchase of common stock (in Shares) | 1,741,865 | 1,741,865 | ||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 9.11 | $ 9.11 | ||||||||||||||||||
| Warrant [Member] | Minimum [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 0.03 | 0.03 | ||||||||||||||||||
| Warrant [Member] | Maximum [Member] | ||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | ||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 9.75 | $ 9.75 | ||||||||||||||||||